Global Metabolomics Market is expected to garner $3.30 billion by 2023 - 1 views

• 
  #1 shawnandrew on 26 Feb 19

   

  Global Metabolomics Market is expected to garner $3.30 billion by 2023, growing a CAGR of 13.2% from 2017 to 2023.
  The drug discovery segment is anticipated to witness the highest grow rate
  The key companies include Agilent Technologies, Inc., Biocrates Life Sciences AG, Danaher Corporation, Leco Corporation,
  Read More: http://bit.ly/2ExQhwi

   

  <div class="cArrow"> </div><div class="cContentInner">Global Metabolomics Market is expected to garner $3.30 billion by 2023, growing a CAGR of 13.2% from 2017 to 2023. <br /> The drug discovery segment is anticipated to witness the highest grow rate <br /> The key companies include Agilent Technologies, Inc., Biocrates Life Sciences AG, Danaher Corporation, Leco Corporation, <br /> Read More: <a href="http://bit.ly/2ExQhwi" rel="nofollow" target="_blank">http://bit.ly/2ExQhwi</a></div>

  ...

  Cancel

To Top